GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XTER:BTI) » Definitions » Tax Rate %

Algernon Pharmaceuticals (XTER:BTI) Tax Rate % : 0.00% (As of Feb. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Algernon Pharmaceuticals's Tax Expense for the three months ended in Feb. 2024 was €0.00 Mil. Algernon Pharmaceuticals's Pre-Tax Income for the three months ended in Feb. 2024 was €-0.69 Mil. Therefore, Algernon Pharmaceuticals's Tax Rate % for the quarter that ended in Feb. 2024 was 0.00%.

Algernon Pharmaceuticals Tax Rate % Historical Data

The historical data trend for Algernon Pharmaceuticals's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Tax Rate % Chart

Algernon Pharmaceuticals Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Tax Rate %
Get a 7-Day Free Trial Premium Member Only - - - - -

Algernon Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Algernon Pharmaceuticals Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Algernon Pharmaceuticals's Tax Rate % for the fiscal year that ended in Aug. 2023 is calculated as

Tax Rate %=Tax Expense (A: Aug. 2023 )/Pre-Tax Income (A: Aug. 2023 )
=0/-4.614
=0.00 %

Algernon Pharmaceuticals's Tax Rate % for the quarter that ended in Feb. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Feb. 2024 )/Pre-Tax Income (Q: Feb. 2024 )
=0/-0.689
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Algernon Pharmaceuticals Tax Rate % Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals (XTER:BTI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XTER:BTI) » Definitions » Tax Rate %
Comparable Companies
XCNQ:MOOD XCNQ:CURE XCNQ:GTTX TSXV:IBO TSXV:PSYB XCNQ:ENBI TSXV:VXL XCNQ:ABRT XCNQ:MYND TSXV:SVS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
AGNPF:USA AGW0:Germany AGN:Canada
Address
601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Website
https://www.algernonpharmaceuticals.com
Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.